BARDA provides CDMO $628m to serve US government
Emergent receives funds to provide manufacturing capabilities to the US government for COVID-19 vaccine candidates.
Emergent receives funds to provide manufacturing capabilities to the US government for COVID-19 vaccine candidates.
Novavax buys Praha Vaccines and gains the capacity to produce over one billion doses of its COVID-19 vaccine candidate.
Eli Lilly’s potential treatment is the first coronavirus-specific mAb to enter trials and large-scale manufacturing efforts will commence immediately.